BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 35600452)

  • 1. Liposomes: structure, composition, types, and clinical applications.
    Nsairat H; Khater D; Sayed U; Odeh F; Al Bawab A; Alshaer W
    Heliyon; 2022 May; 8(5):e09394. PubMed ID: 35600452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes for Tumor Targeted Therapy: A Review.
    Wang S; Chen Y; Guo J; Huang Q
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulus-responsive liposomes for biomedical applications.
    Antoniou AI; Giofrè S; Seneci P; Passarella D; Pellegrino S
    Drug Discov Today; 2021 Aug; 26(8):1794-1824. PubMed ID: 34058372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.
    Nikolova MP; Kumar EM; Chavali MS
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polydopamine-Modified Liposomes: Preparation and Recent Applications in the Biomedical Field.
    Maurelli AM; De Leo V; Catucci L
    ACS Omega; 2024 Jun; 9(23):24105-24120. PubMed ID: 38882106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal Delivery Systems: Design Optimization and Current Applications.
    Abu Lila AS; Ishida T
    Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
    Immordino ML; Dosio F; Cattel L
    Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.
    Abri Aghdam M; Bagheri R; Mosafer J; Baradaran B; Hashemzaei M; Baghbanzadeh A; de la Guardia M; Mokhtarzadeh A
    J Control Release; 2019 Dec; 315():1-22. PubMed ID: 31647978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications.
    Khan AA; Allemailem KS; Almatroodi SA; Almatroudi A; Rahmani AH
    3 Biotech; 2020 Apr; 10(4):163. PubMed ID: 32206497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
    Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
    Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.
    Eloy JO; Claro de Souza M; Petrilli R; Barcellos JP; Lee RJ; Marchetti JM
    Colloids Surf B Biointerfaces; 2014 Nov; 123():345-63. PubMed ID: 25280609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes as nanocarriers for anti-HIV therapy.
    Chopra S; Venkatesan N; Betageri GV
    Drug Deliv Transl Res; 2013 Oct; 3(5):471-8. PubMed ID: 25788354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation,
    Fazel M; Daeihamed M; Osouli M; Almasi A; Haeri A; Dadashzadeh S
    Iran J Pharm Res; 2018; 17(Suppl2):33-43. PubMed ID: 31011340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome technology for drug delivery against mycobacterial infections.
    Khuller GK; Kapur M; Sharma S
    Curr Pharm Des; 2004; 10(26):3263-74. PubMed ID: 15544514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of lipid vesicles of camptothecin as targeted drug delivery system.
    Prabhakara P; Zenia T; Marina K; Shama KP; Girish SN; Matapady NH
    Pak J Pharm Sci; 2013 Jul; 26(4):779-86. PubMed ID: 23811458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thioether Phosphatidylcholine Liposomes: A Novel ROS-Responsive Platform for Drug Delivery.
    Du Y; He W; Xia Q; Zhou W; Yao C; Li X
    ACS Appl Mater Interfaces; 2019 Oct; 11(41):37411-37420. PubMed ID: 31556583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review.
    Abbasi H; Kouchak M; Mirveis Z; Hajipour F; Khodarahmi M; Rahbar N; Handali S
    Adv Pharm Bull; 2023 Jan; 13(1):7-23. PubMed ID: 36721822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart Stimuli-Responsive Liposomal Nanohybrid Systems: A Critical Review of Theranostic Behavior in Cancer.
    Alwattar JK; Mneimneh AT; Abla KK; Mehanna MM; Allam AN
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33800292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stealth Liposomes (PEGylated) Containing an Anticancer Drug Camptothecin: In Vitro Characterization and In Vivo Pharmacokinetic and Tissue Distribution Study.
    Sivadasan D; Sultan MH; Madkhali OA; Alsabei SH; Alessa AA
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.